Galactomannan enzymatic immunoassay cross-reactivity caused by Prototheca species

D Van den Bossche1, A De Bel, M Hendrickx

  • 1Department of Microbiology and Infection Control, Universiteit Brussel, Brussels, Belgium.

Insights

An Aspergillus galactomannan assay showed reactivity in a patient with Prototheca zopfii infection. This suggests potential cross-reactivity in diagnosing invasive protothecosis using this common fungal biomarker.

Area of Science:

  • Medical Mycology
  • Clinical Diagnostics
  • Infectious Diseases

Background:

  • Invasive fungal infections require accurate diagnostic tools.
  • Aspergillus galactomannan assay is a key biomarker for invasive aspergillosis.
  • Prototheca zopfii is an emerging cause of human infections.

Observation:

  • A patient with invasive Prototheca zopfii infection was tested.
  • The serum sample demonstrated reactivity with the Aspergillus galactomannan assay.
  • Supernatants from Prototheca isolates also yielded positive assay results.

Findings:

  • The Aspergillus galactomannan assay exhibits cross-reactivity with Prototheca species.
  • This cross-reactivity was observed in both patient serum and microbial isolates.
  • The diagnostic specificity of the galactomannan assay may be impacted in cases of protothecosis.

Implications:

  • Consider Prototheca infection in patients with positive galactomannan assays, especially if fungal cultures are negative or atypical.
  • Further investigation is needed to understand the mechanism of cross-reactivity.
  • This finding may necessitate the development of more specific diagnostic markers for invasive protothecosis.